imipenem, anhydrous has been researched along with Neutropenia in 92 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (15.22) | 18.7374 |
| 1990's | 45 (48.91) | 18.2507 |
| 2000's | 28 (30.43) | 29.6817 |
| 2010's | 4 (4.35) | 24.3611 |
| 2020's | 1 (1.09) | 2.80 |
| Authors | Studies |
|---|---|
| Buclin, T; Calandra, T; Csajka, C; Lamoth, F; Marchetti, O; Pascual, A | 1 |
| Abdelraouf, K; Berry, AV; Chen, X; Fratoni, AJ; Liu, X; Nicolau, DP; Wu, Y | 1 |
| Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
| Balm, M; Carter, J; Humble, M; Moniwa, A; Roohullah, A; Weinkove, R; Wood, C | 1 |
| Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK | 1 |
| Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Buclin, T; Calandra, T; Lamoth, F; Marchetti, O; Pascual, A | 1 |
| Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
| Jongman, LR; Lugtenburg, PJ; Rijnders, BJ; Slobbe, L; Waal, Lv | 1 |
| Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
| Bayram, I; Erbey, F; Tanyeli, A; Yilma, S | 1 |
| Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Jones, RN; Mutnick, AH; Turner, PJ | 1 |
| Cámara, JC; Casado, A; Díaz-Rubio, E; Flores, L; García-Sáenz, JA; Macias, JA; Manrique, I; Martín, M; Pérez-Segura, P; Perezagua, C | 1 |
| Klastersky, JA | 1 |
| Bellabas, H; Defez, C; Fabbro-Peray, P; Jourdan, E; Jourdan, J; Richard, B; Sotto, A; Topart, D | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Ayalew, K; Jantausch, BA; Nambiar, S; Yasinskaya, Y | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
| Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C | 1 |
| Anagnostopoulos, A; Fassas, A; Hadjikyrkou, M; Kontodimou, A; Papageorgiou, T; Proya, E | 1 |
| Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
| Daikos, GL; Loli, A; Miriagou, V; Panagiotakopoulou, A; Tzelepi, E; Tzouvelekis, LS | 1 |
| Kinik, ST; Onay, OS; Ozbek, N; Ozbek, OY | 1 |
| Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M | 1 |
| Calia, FM; Johnson, DE; Schimpff, SC; Snyder, MJ; Warren, JW | 1 |
| Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ | 1 |
| Ishibashi, T; Okada, H; Omori, S; Sasada, M; Sawada, H; Suzuki, T; Tajima, M; Yamamoto, K; Yasuda, N; Yumoto, Y | 1 |
| Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F | 1 |
| Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
| Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T | 1 |
| Barros, KV; Bianchi, A; Kusano, E; Melaragno, R; Petrilli, AS; Ribeiro, RC; Silva, AA | 1 |
| de Vega, T; Fariñas, MC; Garmendia, J; González-Macías, J | 1 |
| Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
| Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Deaney, NB; Tate, H | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Björkholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
| Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M | 1 |
| Arranz, R; Cámara, R; del Rey, MC; Fernández-Rañada, JM; Figuera, A; Hernández, L; Jiménez, ML; López-Lorenzo, JL; Peñarrubia, MJ; Tomás, JF | 1 |
| Hathorn, JW; Lyke, K | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Gaya, H | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Klastersky, J | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
| Abi-Said, D; Bodey, GP; Karl, CL; Raad, II; Rolston, KV | 1 |
| Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
| Aoun, M; Autier, P; Crokaert, F; Klastersky, J; Paesmans, M | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Kikuchi, K; Matsui, Y; Shiseki, M; Totsuka, K | 1 |
| Daenen, S; de Vries-Hospers, HG; Erjavec, Z; Halie, RM; Laseur, M | 1 |
| Anaissie, EJ; Gubbins, PO; McConnell, SA; Penzak, SR; Warmack, TS | 1 |
| Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
| Arranz, R; de La Cámara, R; Font, P; Leyra, F; María Fernández Rañada, J; Pajuelo, F; Rivero, N | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Kühl, J; Lehrnbecher, T; Stanescu, A | 1 |
| Dotti, M; Giacchino, M; Pavesio, D; Pecco, P | 1 |
| Bareford, D; Bayston, KF; Bint, AJ; Cefai, C; Cohen, J; Leyland, MJ; Murray, SA; Newland, AC; Warren, R; White, DG | 1 |
| Itoh, M; Nakano, T; Sakurai, M | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Branger, T; Cornelissen, JJ; de Graeff, A; Dekker, AW; Rozenberg-Arska, M; Verdonck, LF; Verhoef, J | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV | 1 |
| Riikonen, P | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
| Shevchuk, YM | 1 |
| Huijgens, PC; Langenhuijsen, MM; Ossenkoppele, GJ; Simoons-Smit, AM; van Loenen, AC; van Pampus, EC; Weijers, TF; Wijermans, PW | 1 |
| Anderson, AW; Child, JA; Hawkey, PM; Kerr, KG; Norfolk, DR | 1 |
| Pizzo, PA; Rubin, M | 1 |
| Chan, TK; Chau, PY; Chiu, E; Lam, WK; Liang, R; Todd, D; Yung, R | 1 |
| Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
| Farrell, I; Janmohamed, RM; Kelly, J; Leyland, MJ | 1 |
| Inoue, M; Kawa, K; Konishi, S; Naya, Y; Nishida, M; Sako, M; Yabuuchi, H | 1 |
| Bucaneve, G; Del Favero, A; Menichetti, F; Minotti, V; Pasticci, MB; Tonato, M | 1 |
| Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G | 1 |
| Hashizume, T; Kemi, M; Komatsu, T; Ogashiwa, M; Okumoto, Y; Takase, Z | 1 |
| Fridrik, MA; Grafinger-Witt, E; Leisch, F; Wahl, G | 1 |
| Chan, TK; Chau, PY; Lam, WK; Liang, R; So, SY; Todd, D; Yung, R | 1 |
| Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B | 1 |
| Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
| Andremont, A; Baruchel, A; Hartmann, O; Tancrède, C | 1 |
| Bustamante, C; Devlin, A; Drusano, GL; Forrest, A; Plaisance, KI; Standiford, HC; Wade, JC | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
| Bustamante, CI; deJongh, C; Drusano, GL; Johnson, DE; Joshi, JH; Moody, MR; Schimpff, SC; Standiford, HC; Wade, JC | 1 |
6 review(s) available for imipenem, anhydrous and Neutropenia
| Article | Year |
|---|---|
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins | 2010 |
Use of imipenem as empirical treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia | 2003 |
Carbapenems in pediatrics.
Topics: Child; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Neutropenia; Pneumonia, Bacterial; Thienamycins | 2003 |
A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients.
Topics: Cilastatin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia; Protease Inhibitors; Thienamycins; Treatment Outcome | 1996 |
Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Imipenem; Meropenem; Neutropenia; Thienamycins | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
38 trial(s) available for imipenem, anhydrous and Neutropenia
| Article | Year |
|---|---|
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2010 |
Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Cross-Over Studies; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Time Factors | 2002 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome | 2004 |
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome | 2005 |
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate | 2007 |
[Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
Topics: Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Neutropenia | 1995 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 1994 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin | 1996 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Retreatment; Treatment Outcome | 1996 |
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins | 1996 |
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Thienamycins; Vancomycin | 1996 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
Imipenem versus targeted therapy in cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoses; Neoplasms; Neutropenia; Thienamycins | 1998 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy.
Topics: Adult; Anti-Bacterial Agents; Body Temperature; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Neutropenia; Prospective Studies; Recurrence; Teicoplanin; Thienamycins; Treatment Outcome | 2000 |
[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
Topics: Adolescent; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
Topics: Adolescent; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Imipenem; Infant; Infections; Injections, Intravenous; Male; Neoplasms; Neutropenia; Retrospective Studies; Teicoplanin; Time Factors | 2002 |
A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Fever; Gentamicins; Humans; Imipenem; Leukemia; Lymphoma; Middle Aged; Neutropenia; Piperacillin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.
Topics: Adult; Aged; Cefuroxime; Cephalothin; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection | 1992 |
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin | 1991 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.
Topics: Antibiotics, Antineoplastic; Cilastatin; Drug Resistance, Microbial; Fever; Hematologic Diseases; Humans; Imipenem; Neutropenia; Time Factors | 1991 |
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation; Remission Induction | 1989 |
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins | 1987 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
48 other study(ies) available for imipenem, anhydrous and Neutropenia
| Article | Year |
|---|---|
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Female; Glomerular Filtration Rate; Guidelines as Topic; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Models, Biological; Neutropenia; Young Adult | 2009 |
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing.
Topics: Acinetobacter baumannii; Animals; Bacteria; Bacterial Proteins; Humans; Imipenem; Klebsiella pneumoniae; Mice; Neutropenia | 2023 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Drug Substitution; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome | 2009 |
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
Imipenem underdosing as a cause of persistent neutropenic fever?
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia | 2009 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Colistin; Drug Therapy, Combination; Female; Fever of Unknown Origin; Fluconazole; Fluoroquinolones; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Withholding Treatment; Young Adult | 2009 |
Imipenem in the treatment of febrile neutropenic children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Imipenem; Infant; Male; Medical Records; Neoplasm Staging; Neoplasms; Neutropenia; Retrospective Studies; Survival Rate; Treatment Outcome | 2009 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.
Topics: Adult; Aged; Anti-Bacterial Agents; Escherichia coli; Female; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome | 1989 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Dose-Response Relationship, Drug; Female; Imipenem; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscular Diseases; Neutropenia; Time Factors | 2007 |
Laryngitis and neutropenia from parvovirus-B19.
Topics: Croup; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Imipenem; Immunization, Passive; Infant; Laryngitis; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human | 2007 |
Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
Topics: Agranulocytosis; Animals; Drug Synergism; Female; Imipenem; Lethal Dose 50; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Thienamycins | 1983 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis | 1994 |
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins | 1995 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neutropenia | 1993 |
Severe neutropenia in a patient treated with imipenem/cilastatin.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Neutropenia; Osteomyelitis | 1993 |
Carbapenems in febrile neutropenic patients.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia | 1997 |
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss | 1997 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
Topics: Adolescent; Adult; Aged; Cilastatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Protease Inhibitors; Retrospective Studies; Thienamycins; Treatment Outcome | 1998 |
Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
Topics: Animals; Drug Therapy, Combination; Female; Imipenem; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Staphylococcus aureus; Vancomycin | 1999 |
Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.
Topics: Adult; Aged; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Reactions; Drug Combinations; Drug Hypersensitivity; Fever; Humans; Imipenem; Incidence; Middle Aged; Neutropenia; Penicillins; Retrospective Studies | 2000 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Imipenem use in serious childhood infections.
Topics: Antineoplastic Agents; Bacterial Infections; Child; Cystic Fibrosis; Humans; Imipenem; Neoplasms; Neutropenia; Retrospective Studies; Surgical Wound Infection; Thienamycins; Treatment Outcome | 1991 |
[Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
Topics: Adolescent; Age Factors; Bacterial Infections; Child; Child, Preschool; Cilastatin; Collagen Diseases; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Infant; Male; Neoplasms; Neutropenia; Opportunistic Infections | 1992 |
Antimicrobial agents in neutropenic patients with unexplained fever.
Topics: Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fever of Unknown Origin; Humans; Imipenem; Infections; Neutropenia | 1991 |
Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem.
Topics: Drug Resistance, Microbial; Female; Humans; Imipenem; Neutropenia; Opportunistic Infections; Pseudomonas Infections | 1990 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones | 1990 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
Pharmacokinetics of imipenem/cilastatin in neutropenic patients with haematological malignancies.
Topics: Acute Disease; Adult; Agranulocytosis; Blood Preservation; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia | 1990 |
[Clinical study of imipenem/cilastatin sodium in children with severe infections].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Female; Hematologic Diseases; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia | 1990 |
Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.
Topics: Ampicillin; Animals; Cefazolin; Cilastatin; Cyclopropanes; Drug Combinations; Drug Evaluation, Preclinical; Endometritis; Enterococcus faecalis; Escherichia coli Infections; Female; Imipenem; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Inbred Strains; Streptococcal Infections; Thienamycins | 1987 |
[Imipenem/cilastatin as monotherapy in neutropenic patients with fever].
Topics: Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies | 1988 |
Imipenem/cilastatin as initial therapy for febrile neutropenic patients.
Topics: Agranulocytosis; Cilastatin; Dipeptidases; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Imipenem; Male; Microbial Sensitivity Tests; Neutropenia | 1988 |
Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Topics: Adolescent; Adult; Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Enterobacteriaceae; Female; Gram-Negative Bacteria; Humans; Imipenem; Intestines; Male; Neoplasms; Neutropenia; Thienamycins | 1986 |
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.
Topics: Adult; Aged; Agranulocytosis; Double-Blind Method; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Thienamycins | 1987 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
Topics: Agranulocytosis; Bacterial Infections; Drug Synergism; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Thienamycins | 1985 |